Scientific World Model

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

Showing 1–50 of 62 pages matching "Parkinson's disease"

🧪 Vagal Nerve Stimulation for Parkinson's Disease (NCT07226284)KG

clinical · 3,330 words · 10 hyp15 ana62 exp

🧪 HRG2010 for Parkinson's Disease With Motor Fluctuations (NCT06596876)KG

clinical · 2,956 words · 6 hyp16 ana59 exp

🧪 Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms (NCT05748028)KG

clinical · 2,948 words · 60 hyp58 ana59 exp

🧪 Exergaming With Physical Objects for Upper Limb Rehabilitation in Parkinson's Disease (NCT07475741)KG

clinical · 2,896 words · 4 hyp15 ana59 exp

🧪 Edmond J Safra Accelerating Clinical Trials in Parkinson's Disease (NCT07207057)KG

clinical · 2,883 words · 6 hyp19 ana81 exp

🧪 PI3K/Akt Activator Clinical Trials for Parkinson's DiseaseKG

clinical · 2,599 words · 16 hyp16 ana98 exp

🧪 ARC-IM Adaptive Neurostimulation for Parkinson's DiseaseKG

clinical · 2,504 words · 29 hyp34 ana59 exp

🧪 NCT05881460: Vibrotactile Coordinated Reset for Parkinson's DiseaseKG

clinical · 2,228 words · 15 hyp19 ana72 exp

🧪 BIA 28-6156 for GBA-Parkinson's DiseaseKG

clinical · 2,195 words · 5 hyp14 ana60 exp

🧪 Local Field Potentials of Subthalamic Nucleus in Parkinson's Disease (NCT05820425)KG

clinical · 1,984 words · 1 hyp14 ana81 exp

🧪 Purinergic Receptor Targeted Trials in Parkinson's DiseaseKG

clinical · 1,935 words · 10 hyp22 ana84 exp

🧪 Pexidartinib (PLX3397) CSF1R Inhibitor Parkinson's Disease Trial (NCT04888966)KG

clinical · 1,930 words · 16 hyp17 ana71 exp

🧪 Kenai RNDP-001 Dopaminergic Progenitor Cell Therapy for Parkinson's Disease (NCT07106021)KG

clinical · 1,913 words · 28 hyp30 ana63 exp

🧪 IRL757 for Parkinson's Disease ApathyKG

clinical · 1,786 words · 3 hyp14 ana59 exp

🧪 NCT06530290: Mirtazapine for Anxiety in Parkinson's DiseaseKG

clinical · 1,764 words · 1 hyp13 ana59 exp

🧪 CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Parkinson's Disease (NCT06482268)KG

clinical · 1,687 words · 14 hyp18 ana72 exp

🧪 Apocynin for Parkinson's DiseaseKG

clinical · 1,633 words · 14 hyp13 ana72 exp

🧪 DANU Sports System for Gait/Balance Assessment in Parkinson's Disease (NCT07281794)KG

clinical · 1,604 words · 3 hyp16 ana59 exp

🧪 Prasinezumab Phase 3 Parkinson's Disease Trial (NCT07174310)KG

clinical · 1,598 words · 5 hyp19 ana62 exp

🧪 ACI-35 Alpha-Synuclein Vaccine for Parkinson's DiseaseKG

clinical · 1,546 words · 5 hyp14 ana59 exp

🧪 Mediterranean Diet in Parkinson's Disease (NCT07187739)KG

clinical · 1,513 words · 3 hyp14 ana60 exp

🧪 Psilocybin Therapy for Depression in Parkinson's Disease (NCT06455293)KG

clinical · 1,471 words · 33 hyp29 ana62 exp

🧪 Amino Acid Supplement in Parkinson's Disease (NCT06954662)KG

clinical · 1,468 words · 13 hyp14 ana75 exp

🧪 Circuit-Based DBS for Parkinson's Disease (NCT05658302)KG

clinical · 1,447 words · 5 hyp16 ana59 exp

🧪 Clinical Trials in Parkinson's DiseaseKG

clinical · 1,443 words · 2 hyp14 ana82 exp

🧪 EMST with SpiroGym App for Parkinson's Disease (NCT06942533)KG

clinical · 1,440 words · 3 hyp15 ana59 exp

🧪 SER-252 (PEOZ-Apomorphine) for Parkinson's Disease - NCT07422675KG

clinical · 1,414 words · 4 hyp13 ana59 exp

🧪 Cepharanthine (千金藤素) - Investigational Therapy for Parkinson's DiseaseKG

clinical · 1,414 words · 36 hyp28 ana59 exp

🧪 Anesthesia Choice in STN-DBS for Parkinson's Disease (NCT05550714)KG

clinical · 1,376 words · 1 hyp14 ana59 exp

🧪 Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease (NCT06798844)KG

clinical · 1,370 words · 1 hyp14 ana59 exp

🧪 Neuro-immune Interactome in Parkinson's Disease (NCT07026929)KG

clinical · 1,309 words · 3 hyp14 ana59 exp

🧪 Adaptive Deep Brain Stimulation to Offset STN Dysregulation During Exercise in Parkinson's Disease (NCT06296810)KG

clinical · 1,305 words · 3 hyp30 ana59 exp

🧪 Metformin for Parkinson's Disease - Phase 2/3 Trial (NCT07229651)KG

clinical · 1,298 words · 32 hyp39 ana62 exp

🧪 TB006 Phase 2a Parkinson's Disease Trial (NCT06773962)KG

clinical · 1,295 words · 8 hyp18 ana62 exp

🧪 Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease (NCT06518824)KG

clinical · 1,277 words · 25 hyp39 ana59 exp

🧪 ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's DiseaseKG

clinical · 1,257 words · 4 hyp16 ana64 exp

🧪 Tocotrienols in Parkinson's Disease Trial (NCT04491383)KG

clinical · 1,244 words · 15 hyp14 ana61 exp

🧪 Clinical Efficacy and Mechanism of tDCS for Dysphagia in Parkinson's Disease (NCT07153692)KG

clinical · 1,239 words · 8 hyp15 ana59 exp

🧪 Lithium for Parkinson's Disease - SUNY Buffalo Trial (NCT06339034)KG

clinical · 1,226 words · 3 hyp14 ana64 exp

🧪 Vutiglabridin for Parkinson's DiseaseKG

clinical · 1,220 words · 11 hyp13 ana62 exp

🧪 Self-administered tDCS for Parkinson's Disease GaitKG

clinical · 1,203 words · 7 hyp13 ana59 exp

🧪 Probiotic Treatment for Depression in Parkinson's Disease (NCT05568498)KG

clinical · 1,192 words · 4 hyp13 ana60 exp

🧪 Ultrasonographic Respiratory Muscle Assessment in Parkinson's Disease (NCT07308795)KG

clinical · 1,184 words · 19 hyp32 ana61 exp

🧪 Cionic Neural Sleeve for Parkinson's Disease (NCT07284823)KG

clinical · 1,173 words · 4 hyp14 ana59 exp

🧪 Blood Flow Restriction for Optimizing Balance in Parkinson's Disease (NCT06508801)KG

clinical · 1,167 words · 180 hyp65 ana69 exp

🧪 Terazosin for Cardiac Autonomic Changes in Early Parkinson's Disease (NCT04386317)KG

clinical · 1,146 words · 5 hyp27 ana59 exp

🧪 Autologous Stem Cell-Derived Dopaminergic Neurons for Parkinson's Disease (NCT06687837)KG

clinical · 1,137 words · 13 hyp23 ana72 exp

🧪 Autologous iNSC-DAP Cell Therapy for Parkinson's Disease (NCT05901818)KG

clinical · 1,122 words · 26 hyp30 ana62 exp

🧪 CVN424 Phase 3 ARISE Trial for Parkinson's DiseaseKG

clinical · 1,112 words · 5 hyp18 ana59 exp

🧪 Buntanetap Phase 3 Parkinson's Disease Trial (NCT07284784)KG

clinical · 1,095 words · 3 hyp17 ana60 exp